ProCE Banner Activity

Navigating Endocrine Therapy and Resistance in ER+/HER2- Breast Cancer

Slideset

Download this slideset from a live symposium to learn more about optimizing endocrine therapy for patients with ER+/HER2- breast cancer.

Released: December 01, 2023

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from AstraZeneca.

AstraZeneca